F. Baumgartner

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

S. Haas, C. Weidinger, M. Wirth, 2022, The Journal of clinical investigation.

SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer

T. Michoel, R. Schüle, S. Lassmann, 2015, Molecular oncology.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

F. Bassermann, S. Müller, M. Wirth, 2022, Blood advances.